Anna Maria Barbieri

1.4k total citations
37 papers, 1.1k citations indexed

About

Anna Maria Barbieri is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Surgery. According to data from OpenAlex, Anna Maria Barbieri has authored 37 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Endocrinology, Diabetes and Metabolism, 12 papers in Molecular Biology and 10 papers in Surgery. Recurrent topics in Anna Maria Barbieri's work include Pituitary Gland Disorders and Treatments (16 papers), Adrenal and Paraganglionic Tumors (9 papers) and Genetic Syndromes and Imprinting (6 papers). Anna Maria Barbieri is often cited by papers focused on Pituitary Gland Disorders and Treatments (16 papers), Adrenal and Paraganglionic Tumors (9 papers) and Genetic Syndromes and Imprinting (6 papers). Anna Maria Barbieri collaborates with scholars based in Italy, France and United States. Anna Maria Barbieri's co-authors include Giovanna Mantovani, Annarita Miluzio, Stefano Biffo, Anna Spada, Pier Carlo Marchisio, Hiroaki Kiyokawa, Anne Beugnet, Valentina Gandin, Paolo Beck‐Peccoz and Erika Peverelli and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Development.

In The Last Decade

Anna Maria Barbieri

35 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anna Maria Barbieri Italy	17	599	336	277	228	93	37	1.1k
Consuelo González‐Manchón Spain	18	536 0.9×	165 0.5×	290 1.0×	94 0.4×	34 0.4×	61	1.2k
Jennifer L. Fiori United States	17	542 0.9×	195 0.6×	102 0.4×	178 0.8×	43 0.5×	19	1.1k
Mervi E. Hyvönen Finland	9	511 0.9×	496 1.5×	69 0.2×	158 0.7×	69 0.7×	10	1.3k
Rodger Palmer United Kingdom	13	397 0.7×	494 1.5×	146 0.5×	76 0.3×	38 0.4×	20	915
Noriko Mizusawa Japan	21	440 0.7×	90 0.3×	301 1.1×	173 0.8×	36 0.4×	41	999
Thierry Vilboux United States	23	628 1.0×	530 1.6×	53 0.2×	118 0.5×	39 0.4×	49	1.2k
Albert de la Chapelle Finland	13	544 0.9×	477 1.4×	133 0.5×	74 0.3×	39 0.4×	15	1.3k
Jamila Gupte United States	17	1.1k 1.9×	120 0.4×	53 0.2×	121 0.5×	130 1.4×	23	1.4k
Baoyuan Bi United States	8	564 0.9×	162 0.5×	105 0.4×	216 0.9×	20 0.2×	9	914
Satsuki Matsushima Japan	19	536 0.9×	134 0.4×	89 0.3×	410 1.8×	108 1.2×	38	1.0k

Countries citing papers authored by Anna Maria Barbieri

Since Specialization

Citations

This map shows the geographic impact of Anna Maria Barbieri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Maria Barbieri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Maria Barbieri more than expected).

Fields of papers citing papers by Anna Maria Barbieri

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Maria Barbieri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Maria Barbieri. The network helps show where Anna Maria Barbieri may publish in the future.

Co-authorship network of co-authors of Anna Maria Barbieri

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Maria Barbieri. A scholar is included among the top collaborators of Anna Maria Barbieri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Maria Barbieri. Anna Maria Barbieri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Treppiedi, Donatella, Federica Mangili, Anna Maria Barbieri, et al.. (2025). Potential antitumoral effects of SRPK1 inhibition through modulation of VEGF splicing in pituitary somatotroph tumoral cells. Frontiers in Endocrinology. 16. 1667327–1667327.

Marra, Giusy, Rosa Catalano, Anna Maria Barbieri, et al.. (2024). Therapeutic potential of targeting the FLNA‐regulated Wee1 kinase in adrenocortical carcinomas. International Journal of Cancer. 156(6). 1256–1271.

Catalano, Rosa, Donatella Treppiedi, Anna Maria Barbieri, et al.. (2024). The Novel SSTR3 Agonist ITF2984 Exerts Antimitotic and Proapoptotic Effects in Human Non-Functioning Pituitary Neuroendocrine Tumor (NF-PitNET) Cells. International Journal of Molecular Sciences. 25(7). 3606–3606. 3 indexed citations

Mangili, Federica, Emanuela Esposito, Anna Maria Barbieri, et al.. (2023). A β-Arrestin 2-Biased Dopamine Receptor Type 2 (DRD2) Agonist Is More Efficacious Than Cabergoline in Reducing Cell Proliferation in PRL-Secreting but Not in Non-Functioning Pituitary Tumor Cells. Cancers. 15(12). 3218–3218. 1 indexed citations

Morelli, Valentina, Carmen Aresta, Elena Passeri, et al.. (2022). Adrenalectomy Improves Blood Pressure and Metabolic Control in Patients With Possible Autonomous Cortisol Secretion: Results of a RCT. Frontiers in Endocrinology. 13. 898084–898084. 33 indexed citations

Mangili, Federica, Emanuela Esposito, Donatella Treppiedi, et al.. (2022). DRD2 Agonist Cabergoline Abolished the Escape Mechanism Induced by mTOR Inhibitor Everolimus in Tumoral Pituitary Cells. Frontiers in Endocrinology. 13. 867822–867822. 7 indexed citations

Treppiedi, Donatella, Giusy Marra, Anna Maria Barbieri, et al.. (2021). USP8 inhibitor RA-9 reduces ACTH release and cell growth in tumor corticotrophs. Endocrine Related Cancer. 28(8). 573–582. 14 indexed citations

Morelli, Valentina, Carmen Aresta, Agostino Gaudio, et al.. (2020). Prediction of hypertension, diabetes and fractures in eucortisolemic women by measuring parameters of cortisol milieu. Endocrine. 68(2). 411–419. 17 indexed citations

Mangili, Federica, Elena Giardino, Donatella Treppiedi, et al.. (2020). SAT-312 Beta-Arrestin 2 Is Required for Dopamine Receptor Type 2 Inhibitory Effects on Akt Phosphorylation and Cell Proliferation in Pituitary Tumors. Journal of the Endocrine Society. 4(Supplement_1). 1 indexed citations

10.

Palmieri, Serena, Maria Francesca Bedeschi, Elisa Cairoli, et al.. (2018). Bone involvement and mineral metabolism in Williams’ syndrome. Journal of Endocrinological Investigation. 42(3). 337–344. 5 indexed citations

11.

Zhukouskaya, Volha V., Cristina Eller-Vainicher, Agostino Gaudio, et al.. (2015). In Postmenopausal Female Subjects With Type 2 Diabetes Mellitus, Vertebral Fractures Are Independently Associated With Cortisol Secretion and Sensitivity. The Journal of Clinical Endocrinology & Metabolism. 100(4). 1417–1425. 20 indexed citations

12.

Sala, Elisa, Marcello Filopanti, Emanuele Ferrante, et al.. (2014). Role of IGF1‐(CA)₁₉ promoter microsatellite in the clinical presentation of acromegaly. European Journal of Clinical Investigation. 44(12). 1222–1229. 2 indexed citations

13.

Filopanti, Marcello, Anna Maria Barbieri, Giovanna Mantovani, et al.. (2013). Role of UGT1A1 and ADH gene polymorphisms in pegvisomant-induced liver toxicity in acromegalic patients. European Journal of Endocrinology. 170(2). 247–254. 12 indexed citations

14.

Elli, Francesca Marta, Anna Maria Barbieri, Paolo Bordogna, et al.. (2013). Screening for GNAS genetic and epigenetic alterations in progressive osseous heteroplasia: First Italian series. Bone. 56(2). 276–280. 24 indexed citations

15.

Giavoli, Claudia, Eriselda Profka, Elisa Sala, et al.. (2013). Impact of IGF(CA)19 gene polymorphism on the metabolic response to GH therapy in adult GH-deficient patients. European Journal of Endocrinology. 170(2). 273–281. 3 indexed citations

16.

Terranegra, Annalisa, Anita Ferraretto, Elena Dogliotti, et al.. (2010). Calcimimetic R-568 effects on activity of R990G polymorphism of calcium-sensing receptor. Journal of Molecular Endocrinology. 45(4). 245–256. 22 indexed citations

17.

Mantovani, Giovanna, Luisa De Sanctis, Anna Maria Barbieri, et al.. (2010). Pseudohypoparathyroidism andGNASEpigenetic Defects: Clinical Evaluation of Albright Hereditary Osteodystrophy and Molecular Analysis in 40 Patients. The Journal of Clinical Endocrinology & Metabolism. 95(2). 651–658. 110 indexed citations

18.

Ermetici, Federica, Alexis Elias Malavazos, Alberto Dolci, et al.. (2009). Peripheral insulin-like factor 3 concentrations are reduced in men with type 2 diabetes mellitus: effect of glycemic control and visceral adiposity on Leydig cell function. European Journal of Endocrinology. 161(6). 853–859. 27 indexed citations

19.

Masserini, Benedetta, Valentina Morelli, S. Bergamaschi, et al.. (2008). The limited role of midnight salivary cortisol levels in the diagnosis of subclinical hypercortisolism in patients with adrenal incidentaloma. European Journal of Endocrinology. 160(1). 87–92. 88 indexed citations

20.

Gandin, Valentina, Annarita Miluzio, Anna Maria Barbieri, et al.. (2008). Eukaryotic initiation factor 6 is rate-limiting in translation, growth and transformation. Nature. 455(7213). 684–688. 179 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact